MIMETOGEN PHARMACEUTICALS INC. CLOSES SERIES A FINANCING

Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately held drug development company, announced today that it has successfully completed a Series A equity financing led by Boston-based VIMAC Milestone Medica Fund with MSBi Capital returning as a co-investor. The Company has also completed negotiations with McGill University, Montréal for the exclusive worldwide rights to develop and commercialize novel technologies and therapeutics in the areas of cancer and glaucoma.
CNW Group